A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 1,211,138 shares of DAWN stock, worth $17.5 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,211,138
Previous 1,256,570 3.62%
Holding current value
$17.5 Million
Previous $20.8 Million 19.6%
% of portfolio
0.33%
Previous 0.41%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.03 - $17.69 $546,546 - $803,692
-45,432 Reduced 3.62%
1,211,138 $16.7 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $17.46 $17 Million - $21.9 Million
1,256,570 New
1,256,570 $20.8 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1.06B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.